Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: Results from the multinational COMORA study

Annals of the Rheumatic Diseases

Volumn 75, Issue 3, 2016, Pages 540-546

  Putrik, Polina ^a,b   Ramiro, Sofia ^c,d   Keszei, Andras P ^e   Hmamouchi, Ihsane ^f   Dougados, Maxime ^g   Uhlig, Till ^h   Kvien, Tore K ^h   Boonen, Annelies ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d HOSPITAL GARCIA DE ORTA   (Portugal)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f MOHAMMED V UNIVERSITY   (Morocco)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ADULT; AGE; ARTICLE; CROSS-SECTIONAL STUDY; DAS28; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG COST; DRUG USE; EDUCATIONAL STATUS; EGYPT; FEMALE; FRANCE; GENDER; GROSS NATIONAL PRODUCT; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SOCIAL STATUS; AGED; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; DEMOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SOCIAL CLASS; STATISTICAL MODEL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; EGYPT; FEMALE; FRANCE; GROSS DOMESTIC PRODUCT; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIAL CLASS;

EID: 84960100729     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206737     Document Type: Article

References (25)

1. Whitehead M, Dahlgren G, Gilson L. Developing the policy response to inequities in Health: a global perspective. In: Challenging inequities in health care: from ethics to action. New York: Oxford University Press, 2001:309-22.
2. Mackenbach JP, Karanikolos M, McKee M. The unequal health of Europeans: successes and failures of policies. Lancet 2013;381:1125-34.
3. Marmot M, Allen J, Bell R, et al. WHO European review of social determinants of health and the health divide. Lancet 2012;380:1011-29.
4. Massardo L, Pons-Estel BA, Wojdyla D, et al. Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline. Arthritis Care Res (Hoboken) 2012;64:1135-43.
5. Symmons DP. Environmental factors and the outcome of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:717-27.
6. Callahan LF, Pincus T. Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum 1988;31:1346-57.
7. Jordan JM. Effect of race and ethnicity on outcomes in arthritis and rheumatic conditions. Curr Opin Rheumatol 1999;11:98-103.
8. Sokka T, Kautiainen H, Pincus T, et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009;68:1666-72.
9. Putrik P, Ramiro S, Kvien TK, et al. Inequities in access to biologic and synthetic DMARDs across 46 European countries. Ann Rheum Dis 2014;73:198-206.
10. Putrik P, Ramiro S, Kvien TK, et al. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth? Ann Rheum Dis 2014;73:2010-21.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014;73:62-8.
13. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva, 2000.
14. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva, 1995.
15. Wolfe F, Michaud K, Li T, et al. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol 2010;37:305-15.
16. England BR, Sayles H, Mikuls TR, et al. Validation of the Rheumatic Disease Comorbidity Index. Arthritis Care Res (Hoboken) 2014.
17. World Economic Outlook Database [database on the Internet]. 2011 [cited June, 2014]. http://www.imf.org/external/pubs/ft/weo/2011/02/weodata/index.aspx
18. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
19. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
20. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-91.
21. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP, 2011.
22. van Gestel AM, Prevoo ML, van 't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
23. Yelin E, Tonner C, Kim SC, et al. Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study. Arthritis Care Res (Hoboken) 2014;66:980-9.
24. Putrik P, Sokka T, Ramiro S, et al. Impact of socioeconomic gradients within and between countries on health of patients with rheumatoid arthritis (RA): lessons from QUEST RA. Best Pract Res Clin Rheumatol 2012;26:705-20.
25. Magnien F. The measure of GDP per capita in purchasing power standards (PPS): a statistical indicator tricky to interpret. OECD working paper, 2002.